Hydrochlorothiazide PCD Pharma Franchise Company
Cafoli Lifecare offers 19 Hydrochlorothiazide tablet formulations, including single-agent and combination products, for PCD pharma franchise and third-party manufacturing. Every batch is produced in WHO-GMP certified facilities, giving distributors a broad antihypertensive portfolio.
What is Hydrochlorothiazide?
Hydrochlorothiazide is a thiazide diuretic. It acts on the distal renal tubule to increase excretion of sodium and water, reducing blood volume and lowering blood pressure. It is one of the most widely used first-line agents for hypertension. See MedlinePlus for detailed drug information.
Therapeutic Applications
Hydrochlorothiazide is used to treat hypertension and to manage oedema associated with heart failure, renal and hepatic conditions. It is very commonly combined with ACE inhibitors, ARBs and other antihypertensives. It is prescribed by cardiologists, physicians, nephrologists and general practitioners.
Why Hydrochlorothiazide is a High-Potential Molecule for Distributors
Hypertension affects a very large share of India’s adult population, and thiazide diuretics remain a cornerstone of first-line therapy. Because hydrochlorothiazide appears in dozens of fixed-dose antihypertensive combinations taken lifelong, a franchise partner can offer a wide, high-repeat cardiovascular range from one molecule — ideal for building steady chronic-care revenue.
Why Choose Cafoli Lifecare
Cafoli Lifecare supports partners with monopoly PCD rights, WHO-GMP manufacturing, DCGI-approved formulations, complete promotional inputs and a network of 1000+ franchise partners across India.
References
- MedlinePlus – Hydrochlorothiazide
- WHO Model List of Essential Medicines
- PubChem – Hydrochlorothiazide
Our formulations of Hydrochlorothiazide find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: